Holen Sie sich die Stockscreener-App
105.28
3.22%
3.28
Vorhandelsmarkt:
105.95
0.67
+0.64%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt LRCX?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$102.00
Offen:
$102.65
24-Stunden-Volumen:
11.88M
Relative Volume:
1.16
Marktkapitalisierung:
$134.67B
Einnahmen:
$18.44B
Nettoeinkommen (Verlust:
$5.36B
KGV:
25.31
EPS:
4.16
Netto-Cashflow:
$5.41B
1W Leistung:
+8.90%
1M Leistung:
+3.49%
6M Leistung:
+29.07%
1J Leistung:
+29.83%
1-Tages-Spanne:
$101.39
$105.64
1-Wochen-Bereich:
$94.27
$105.64
52-Wochen-Spanne:
$56.32
$105.64
Lam Research Corp Stock (LRCX) Company Profile
Firmenname
Lam Research Corp
Sektor
Telefon
(510) 659-0200
Adresse
4650 CUSHING BLVD, FREMONT, CA
Vergleichen Sie LRCX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LRCX
Lam Research Corp
|
105.28 | 129.41B | 18.44B | 5.36B | 5.41B | 4.16 |
|
ASML
Asml Holding Nv
|
741.79 | 283.62B | 34.95B | 10.67B | 9.97B | 27.22 |
|
AMAT
Applied Materials Inc
|
188.45 | 147.96B | 28.09B | 6.76B | 5.86B | 8.22 |
|
KLAC
Kla Corp
|
935.53 | 120.11B | 12.16B | 4.06B | 3.74B | 30.39 |
|
TER
Teradyne Inc
|
111.63 | 16.65B | 2.91B | 577.07M | 608.44M | 3.54 |
Lam Research Corp Stock (LRCX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-31 | Herabstufung | Summit Insights | Buy → Hold |
| 2025-07-31 | Bestätigt | TD Cowen | Buy |
| 2025-07-10 | Eingeleitet | Goldman | Buy |
| 2025-04-24 | Bestätigt | TD Cowen | Buy |
| 2025-03-20 | Fortgesetzt | Oppenheimer | Outperform |
| 2025-02-20 | Hochstufung | Susquehanna | Neutral → Positive |
| 2025-01-30 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2025-01-30 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2025-01-17 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-01-15 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2024-12-17 | Eingeleitet | Cleveland Research | Neutral |
| 2024-08-01 | Bestätigt | TD Cowen | Buy |
| 2024-05-13 | Eingeleitet | Jefferies | Buy |
| 2024-04-25 | Bestätigt | TD Cowen | Buy |
| 2024-04-19 | Hochstufung | B. Riley Securities | Neutral → Buy |
| 2024-04-18 | Bestätigt | Needham | Buy |
| 2024-04-16 | Eingeleitet | Evercore ISI | Outperform |
| 2024-04-11 | Fortgesetzt | Deutsche Bank | Hold |
| 2024-01-25 | Bestätigt | TD Cowen | Outperform |
| 2024-01-23 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2023-12-12 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2023-12-08 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2023-11-22 | Eingeleitet | Redburn Atlantic | Buy |
| 2023-10-17 | Eingeleitet | Raymond James | Outperform |
| 2023-10-13 | Hochstufung | Needham | Hold → Buy |
| 2023-09-15 | Eingeleitet | Wolfe Research | Outperform |
| 2023-07-24 | Bestätigt | Mizuho | Buy |
| 2023-07-24 | Hochstufung | Stifel | Hold → Buy |
| 2023-04-20 | Bestätigt | Berenberg | Buy |
| 2023-04-20 | Bestätigt | Evercore ISI | Outperform |
| 2023-04-20 | Bestätigt | JP Morgan | Overweight |
| 2023-04-20 | Bestätigt | Jefferies | Buy |
| 2023-04-20 | Bestätigt | Mizuho | Buy |
| 2023-04-20 | Bestätigt | Stifel | Hold |
| 2023-04-20 | Bestätigt | Wells Fargo | Equal Weight |
| 2023-03-13 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2023-01-18 | Fortgesetzt | Stifel | Hold |
| 2022-12-12 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2022-10-20 | Bestätigt | B. Riley Securities | Neutral |
| 2022-10-20 | Bestätigt | BofA Securities | Buy |
| 2022-10-20 | Bestätigt | DA Davidson | Neutral |
| 2022-10-20 | Bestätigt | Evercore ISI | Outperform |
| 2022-10-20 | Bestätigt | JP Morgan | Overweight |
| 2022-10-20 | Bestätigt | Jefferies | Buy |
| 2022-10-20 | Hochstufung | Summit Insights | Hold → Buy |
| 2022-10-20 | Bestätigt | Wells Fargo | Equal Weight |
| 2022-07-25 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2022-06-15 | Herabstufung | B. Riley Securities | Buy → Neutral |
| 2022-01-27 | Bestätigt | Barclays | Overweight |
| 2022-01-27 | Bestätigt | Deutsche Bank | Hold |
| 2022-01-27 | Bestätigt | Evercore ISI | Outperform |
| 2022-01-27 | Bestätigt | Stifel | Buy |
| 2022-01-27 | Bestätigt | Susquehanna | Neutral |
| 2022-01-27 | Bestätigt | UBS | Buy |
| 2022-01-26 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-01-12 | Bestätigt | Barclays | Overweight |
| 2022-01-10 | Bestätigt | BofA Securities | Buy |
| 2022-01-05 | Fortgesetzt | Jefferies | Buy |
| 2021-12-15 | Bestätigt | Deutsche Bank | Hold |
| 2021-10-21 | Bestätigt | B. Riley Securities | Buy |
| 2021-10-21 | Herabstufung | Summit Insights | Buy → Hold |
| 2021-10-15 | Eingeleitet | Piper Sandler | Neutral |
| 2021-09-14 | Herabstufung | Susquehanna | Positive → Neutral |
| 2021-09-07 | Herabstufung | Exane BNP Paribas | Outperform → Neutral |
| 2021-07-29 | Bestätigt | Mizuho | Buy |
| 2021-07-29 | Bestätigt | Stifel | Buy |
| 2021-07-29 | Bestätigt | UBS | Buy |
| 2021-07-29 | Bestätigt | Wells Fargo | Equal Weight |
| 2021-03-31 | Eingeleitet | Bernstein | Outperform |
| 2021-01-28 | Bestätigt | Cowen | Outperform |
| 2021-01-08 | Herabstufung | Needham | Buy → Hold |
| 2020-12-17 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2020-10-22 | Bestätigt | Goldman | Buy |
| 2020-10-22 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2020-10-22 | Bestätigt | Mizuho | Buy |
| 2020-10-22 | Bestätigt | Morgan Stanley | Overweight |
| 2020-10-22 | Bestätigt | RBC Capital Mkts | Outperform |
| 2020-10-22 | Bestätigt | Stifel | Buy |
| 2020-10-22 | Bestätigt | UBS | Buy |
| 2020-09-21 | Hochstufung | Stifel | Hold → Buy |
| 2020-07-30 | Bestätigt | Cowen | Outperform |
| 2020-07-21 | Hochstufung | B. Riley FBR | Neutral → Buy |
| 2020-06-22 | Herabstufung | Stifel | Buy → Hold |
| 2020-06-16 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-05-26 | Eingeleitet | Barclays | Overweight |
| 2020-04-23 | Bestätigt | Needham | Buy |
| 2020-04-08 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2020-04-03 | Hochstufung | Nomura | Neutral → Buy |
| 2020-04-02 | Herabstufung | DA Davidson | Buy → Neutral |
| 2020-03-27 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2020-03-27 | Hochstufung | UBS | Sell → Buy |
Alle ansehen
Lam Research Corp Aktie (LRCX) Neueste Nachrichten
Lam Research Corp: Navigating the Financial Risks of Global Health Crises - TipRanks
Lam Research Corporation (NASDAQ:LRCX) Shares Sold by Mizuho Securities USA LLC - MarketBeat
Zions Bancorporation National Association UT Takes $616,000 Position in Lam Research Corporation (NASDAQ:LRCX) - MarketBeat
Lam Research (NASDAQ:LRCX) Stock Price Up 3%Time to Buy? - MarketBeat
LRCX vs. AMAT: Which Chip-Equipment Stock Is a Better Buy Right Now? - The Globe and Mail
Lam Research Corporation (NASDAQ:LRCX) Shares Bought by Russell Investments Group Ltd. - MarketBeat
AIA Group Ltd Boosts Stock Holdings in Lam Research Corporation (NASDAQ:LRCX) - MarketBeat
Covington Investment Advisors Inc. Acquires 9,540 Shares of Lam Research Corporation (NASDAQ:LRCX) - MarketBeat
Independent Advisor Alliance Boosts Stock Holdings in Lam Research Corporation (NASDAQ:LRCX) - MarketBeat
Lam Research Corporation (NASDAQ:LRCX) Shares Sold by Linscomb Wealth Inc. - MarketBeat
Frank Rimerman Advisors LLC Purchases 18,681 Shares of Lam Research Corporation (NASDAQ:LRCX) - MarketBeat
Invesco Ltd. Boosts Holdings in Lam Research Corporation (NASDAQ:LRCX) - MarketBeat
12,664 Shares in Lam Research Corporation (NASDAQ:LRCX) Bought by Fiduciary Family Office LLC - MarketBeat
Lam Research Corporation (NASDAQ:LRCX) Stock Holdings Increased by Chicago Partners Investment Group LLC - MarketBeat
Lam Research Filing for Automatic Mixed Securities Shelf to Enhance Financial Flexibility - AInvest
LAM RESEARCH CORP SEC 10-K Report - TradingView
Lam Research (NASDAQ:LRCX) Hits New 52-Week HighStill a Buy? - MarketBeat
Lam Research stock hits 52-week high at 103.9 USD By Investing.com - Investing.com Nigeria
Lam Research stock hits 52-week high at 103.9 USD - Investing.com
Lam Research Corporation (NASDAQ:LRCX) Shares Bought by Motley Fool Asset Management LLC - MarketBeat
National Bank of Canada FI Cuts Holdings in Lam Research Corporation (NASDAQ:LRCX) - MarketBeat
King Luther Capital Management Corp Has $7.03 Million Stock Position in Lam Research Corporation (NASDAQ:LRCX) - MarketBeat
Keystone Investors PTE Ltd. Invests $1.80 Million in Lam Research Corporation (NASDAQ:LRCX) - MarketBeat
ASR Vermogensbeheer N.V. Takes $8.73 Million Position in Lam Research Corporation (NASDAQ:LRCX) - MarketBeat
Forsta AP Fonden Has $28.99 Million Holdings in Lam Research Corporation (NASDAQ:LRCX) - MarketBeat
Swiss National Bank Trims Stock Holdings in Lam Research Corporation (NASDAQ:LRCX) - MarketBeat
Pinpoint Asset Management Ltd Invests $1.32 Million in Lam Research Corporation (NASDAQ:LRCX) - MarketBeat
Blair William & Co. IL Sells 10,280 Shares of Lam Research Corporation (NASDAQ:LRCX) - MarketBeat
Lam Research (NASDAQ:LRCX) Trading 2.3% HigherTime to Buy? - MarketBeat
Scotia Capital Inc. Reduces Position in Lam Research Corporation (NASDAQ:LRCX) - MarketBeat
First American Trust FSB Grows Stock Holdings in Lam Research Corporation (NASDAQ:LRCX) - MarketBeat
CCM Investment Group LLC Invests $4.99 Million in Lam Research Corporation (NASDAQ:LRCX) - MarketBeat
Benjamin Edwards Inc. Purchases 21,823 Shares of Lam Research Corporation (NASDAQ:LRCX) - MarketBeat
Sierra Summit Advisors LLC Decreases Stock Holdings in Lam Research Corporation (NASDAQ:LRCX) - MarketBeat
Townsquare Capital LLC Buys 10,539 Shares of Lam Research Corporation (NASDAQ:LRCX) - MarketBeat
Wealthspire Advisors LLC Buys 17,443 Shares of Lam Research Corporation (NASDAQ:LRCX) - MarketBeat
Lam Research Corporation (NASDAQ:LRCX) Stake Lifted by Goldman Sachs Group Inc. - MarketBeat
Lam Research Corporation (NASDAQ:LRCX) Shares Sold by Deutsche Bank AG - MarketBeat
Lam Research Corporation (LRCX): A Bull Case Theory - MSN
AI Is on Sale: 2 Stocks Worth Buying Before the Next Surge - The Motley Fool
True North Advisors LLC Buys Shares of 34,664 Lam Research Corporation (NASDAQ:LRCX) - MarketBeat
Lam Research Corporation (NASDAQ:LRCX) Shares Acquired by MUFG Securities EMEA plc - MarketBeat
Charles Schwab Investment Management Inc. Acquires 418,077 Shares of Lam Research Corporation (NASDAQ:LRCX) - MarketBeat
New Age Alpha Advisors LLC Takes Position in Lam Research Corporation (NASDAQ:LRCX) - MarketBeat
Vanguard Group Inc. Has $9.39 Billion Stock Position in Lam Research Corporation (NASDAQ:LRCX) - MarketBeat
West Michigan Advisors LLC Makes New Investment in Lam Research Corporation (NASDAQ:LRCX) - MarketBeat
Commonwealth Equity Services LLC Has $32.47 Million Stock Holdings in Lam Research Corporation (NASDAQ:LRCX) - MarketBeat
ABC Arbitrage SA Has $1.57 Million Holdings in Lam Research Corporation (NASDAQ:LRCX) - MarketBeat
Mitsubishi UFJ Asset Management Co. Ltd. Boosts Stock Position in Lam Research Corporation (NASDAQ:LRCX) - MarketBeat
WealthPlan Investment Management LLC Invests $710,000 in Lam Research Corporation (NASDAQ:LRCX) - MarketBeat
MWA Asset Management Buys 5,484 Shares of Lam Research Corporation (NASDAQ:LRCX) - MarketBeat
Finanzdaten der Lam Research Corp-Aktie (LRCX)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.79%
0.30%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):